Risultati della ricerca - Gibson, Michael
- Mostra 1 - 20 risultati su 46
- Vai alla pagina seguente
-
1
-
2
-
3
-
4
-
5
-
6
A Rare Case of Malignant Glomus Tumor of the Esophagus di Bali, Gurvinder Singh, Hartman, Douglas J., Haight, Joel B., Gibson, Michael K.
Pubblicazione 2013testo -
7
Inherited disorders of GABA metabolism di Pearl, Phillip L, Hartka, Thomas R, Cabalza, Jessica L, Taylor, Jacob, Gibson, Michael K
Pubblicazione 2006testo -
8
-
9
Atrial Conduction Slows Immediately Before the Onset of Human Atrial Fibrillation: A Bi-Atrial Contact Mapping Study of Transitions to Atrial Fibrillation di Lalani, Gautam G., Schricker, Amir, Gibson, Michael, Rostamian, Armand, Krummen, David E., Narayan, Sanjiv M.
Pubblicazione 2012testo -
10
Non-small cell lung cancer cells survived ionizing radiation treatment display cancer stem cell and epithelial-mesenchymal transition phenotypes di Gomez-Casal, Roberto, Bhattacharya, Chitralekha, Ganesh, Nandita, Bailey, Lisa, Basse, Per, Gibson, Michael, Epperly, Michael, Levina, Vera
Pubblicazione 2013testo -
11
-
12
A propensity-matched analysis comparing survival after primary minimally invasive esophagectomy followed by adjuvant therapy to neoadjuvant therapy for esophagogastric adenocarcino... di Zahoor, Haris, Luketich, James D., Levy, Ryan M., Awais, Omar, Winger, Daniel G., Gibson, Michael K., Nason, Katie S.
Pubblicazione 2014testo -
13
-
14
A Novel Pharmacodynamic Approach to Assess and Predict Tumor Response to the Epidermal Growth Factor Receptor Inhibitor Gefitinib in Patients with Esophageal Cancer di Altiok, Soner, Mezzadra, Heather, Jagannath, Sanjay, Tsottles, Nancy, Rudek, Michelle A, Abdallah, Nadia, Berman, David, Forastiere, Arlene, Gibson, Michael K.
Pubblicazione 2010testo -
15
-
16
-
17
Characterization of rubella-specific humoral immunity following two doses of MMR vaccine using proteome microarray technology di Haralambieva, Iana H., Gibson, Michael J., Kennedy, Richard B., Ovsyannikova, Inna G., Warner, Nathaniel D., Grill, Diane E., Poland, Gregory A.
Pubblicazione 2017testo -
18
A Phase II Study of Bevacizumab in Combination with Docetaxel and Radiation in Locally Advanced Squamous Cell Carcinoma of the Head and Neck di Yao, Min, Galanopoulos, Nicholas, Lavertu, Pierre, Fu, Pingfu, Gibson, Michael, Argiris, Athanassios, Rezaee, Rod, Zender, Chad, Wasman, Jay, Machtay, Mitchell, Savvides, Panos
Pubblicazione 2014testo -
19
Phase II Study of Erlotinib and Docetaxel with Concurrent Intensity Modulated Radiotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma di Yao, Min, Lavertu, Pierre, Savvides, Panayiotis, Woods, Charles, Fu, Pingfu, Gibson, Michael, Rezaee, Rod, Zender, Chad, Wasman, Jay, Sharma, Neelesh, Machtay, Mitchell
Pubblicazione 2016testo -
20
Phase II Study of Irinotecan Plus Panitumumab as Second‐Line Therapy for Patients with Advanced Esophageal Adenocarcinoma di Yoon, Harry, Karapetyan, Lilit, Choudhary, Anita, Kosozi, Ramla, Bali, Gurvinder Singh, Zaidi, Ali H., Atasoy, Ajlan, Forastiere, Arlene A., Gibson, Michael K.
Pubblicazione 2018testo